One House Three Owners How the American Dream of Homeownership Grows More Costly SpaceX OpenAI and Anthropic Could Surpass Berkshire Hathaways Valuation on Day One of Trading Polymarket Traders Suggest SpaceXs IPO Prospects Highlight Starlink Dependency for Growth and Profitability New York Yankees Face Financial Uncertainty as Concerns Over Aaron Judge Grow Prediction Market Investments Continue Despite Regulatory Uncertainty Companies Reaffirm Growth Plans in Earnings Calls Sensex Dips 142 Points Nifty Holds Above 23900 as Mid SmallCaps Outperform OHI Q1 2026 Earnings REIT Beats EPS Estimates Despite Soft Market Reaction AAUC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response SCHL Q1 2026 Earnings EPS Beats Estimates as Scholastic Posts SmallerThanExpected Loss PAA Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Resilience ESOA Q1 2026 Earnings EPS Surges Past Estimates with 743 Surprise TRIB Q4 2024 Earnings Significant EPS Miss Despite Stock Uptick Globavend Holdings GVH Surges Over 6 Key Levels and Volume Dynamics Bold Eagle Acquisition Corp BEAG Holds Steady Near 1058 as Support and Resistance Levels Come into Focus Peoples Financial Services Corp PFIS Struggles Near Midpoint of Recent Range SmithMidland SMID Gains 33 as Price Nears Key Resistance Level RingCentral RNG Holds Steady Near 4260 Amid Cautious Market Sentiment SYY Q1 2026 Earnings EPS Miss Slightly as Cost Pressures Weigh Imperial Petroleum Inc 875 Series A Preferred Shares IMPPP Q1 2026 Earnings Strong Earnings Beat Highlights Operational Efficiency AMT Q1 2026 Earnings Strong EPS Beat Driven by Solid Operational Performance TOL Q1 2026 Earnings Earnings Beat Expectations as Homebuilder Navigates Market Conditions MNPR Q1 2026 Earnings Surprise EPS Beat in PreRevenue Biotech OM Q1 2026 Earnings EPS Misses Estimates as Outset Medical Posts WiderThanExpected Loss Stock Edges Up Quantinuum Eyes 13 Billion Valuation in Potential Landmark Quantum IPO PDLB Q4 2025 Earnings EPS Surges Past Estimates Revenue Details Withheld Decoy Therapeutics DCOY Surges 135 Testing Key Resistance at 767